Solara Active Pharma Sciences Limited (NSE:SOLARA)
India · Delayed Price · Currency is INR 749.85
+42.60 (6.02%)
Sep 11, 2026, 3:29 PM IST
Solara Active Pharma Sciences Employees
Solara Active Pharma Sciences had 1,669 employees as of March 31, 2026. The number of employees decreased by 106 or -5.97% compared to the previous year.
Employees
1,669
Change (1Y)
-106
Growth (1Y)
-5.97%
Revenue / Employee
8.58M INR
Profits / Employee
-9.71K INR
Market Cap
36.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 1,669 | -106 | -5.97% |
| Mar 31, 2025 | 1,775 | -381 | -17.67% |
| Mar 31, 2024 | 2,156 | -205 | -8.68% |
| Dec 31, 2023 | 2,205 | -156 | -6.61% |
| Mar 31, 2023 | 2,361 | 107 | 4.75% |
| Mar 31, 2022 | 2,254 | -321 | -12.47% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Aarti Pharmalabs | 2,421 |
| Jagsonpal Pharmaceuticals | 1,399 |
| Windlas Biotech | 1,385 |
| RPG Life Sciences | 1,366 |
| Ind-Swift Laboratories | 1,246 |
| Orchid Pharma | 736 |
| Sakar Healthcare | 435 |
Solara Active Pharma Sciences News
- 4 months ago - Solara Active Pharma share price jumps over 4% after USFDA closes Puducherry facility inspection with VAI status - Business Upturn
- 9 months ago - Solara Active Pharma’s Mangalore facility clears US FDA inspection with VAI classification - Business Upturn
- 10 months ago - Solara Active Pharma shares slump nearly 9% today after reporting Q2 net loss - Business Upturn
- 1 year ago - Solara Active Pharma shares rise 4% after Ambernath facility clears USFDA inspection with zero observations - Business Upturn
- 1 year ago - Solara Active Pharma shares down 5% as Managing Director Poorvank Purohit resigns - Business Upturn
- 1 year ago - Solara Active Pharma Sciences announces demerger of CRAMS and Polymers business - Business Upturn
- 1 year ago - Solara Active Pharma Sciences Q3 FY25 Results: Revenue up 41.6% YoY to Rs 300.31 crore - Business Upturn